Make sure you follow Collective Evolution on Telegram as we have no idea how much longer we will be on Facebook.
What Happened: Another lawsuit has been filed against Merck for allegedly causing another life-changing disability. As lawyer Robert F. Kennedy Jr. explains, “Before he got the Gardasil (human papillomavirus) vaccine, our client Michael Colbath was a superlative athlete and scholar. A happy, healthy and active boy. In the months following his first injection, exhaustion and extreme fatigue forced Michael away from the sports and hobbies that had been centerpieces of his life. He had trouble staying awake during the school day. After his second Gardasil injection, Michael developed severe foot pain in both feet, so severe that he needed crutches to attend school. He had trouble waking up in the morning and getting out of bed.”
He goes on to explain:
As his symptoms worsened, multiple physicians and specialists treated him for migraine headaches; body pains and muscle aches; chronic fatigue; hypersomnolence (sleeping 15-22 hours in a 24-hour period), sleep drunkenness, unrefreshing sleep; excessive sweating, lightheadedness, and tachycardia; tunnel vision on standing; difficulty with concentration and memory; confusion and brain fog; intermittent or episodic paralysis, numbness; and stomach pains.
Michael’s post-Gardasil injuries and diagnoses, including postural orthostatic tachycardia syndrome (POTS), idiopathic hypersomnia (IH), myalgic encephalomyelitis / chronic fatigue syndrome (ME / CFS), complex regional pain syndrome (CRPS) and gastroparesis, kept him from his passions, sports and hobbies. He missed most of high school and only his formidable self-discipline allowed him to complete his school work at home — he could not walk or move unassisted, he earned his Eagle Scout award using a knee scooter.
If Mrs. Colbath had known that Gardasil could create these health issues, she never would have allowed him to receive it.
This is the fifth Gardasil lawsuit Baum Hedlund and I have filed against Merck challenging the company’s dangerous and defective HPV vaccine for causing severe and life changing injuries. In addition to Mike’s case filed this week, we have filed cases on behalf of Sahara Walker of Wisconsin, Zach Otto of Colorado and Julia Balasco of Rhode Island. While each case is unique, they share common threads: All of our clients were happy, healthy, bright, active kids with unlimited potential until they received the Gardasil HPV vaccine. We look forward to getting these cases in front of a jury as soon as possible.
Kennedy and his team are currently engaged in five lawsuits regarding injury as a result of the HPV vaccine. I recently wrote about Sahara Walker, a 19 year old girl from Wisconsin who suffered debilitating injuries after receiving the vaccine. You can read more about that here.
How Necessary Is The Gardasil Vaccine? The HPV vaccine is heavily marketed as a preventer of cervical cancer, but many studies have called this assumption into question. For example, in a recent study published in The Royal Society of Medicine, researchers conducted an appraisal of published phase 2 and 3 efficacy trials in relation to the prevention of cervical cancer and their analysis showed “the trials themselves generated significant uncertainties undermining claims of efficacy” in the data they used. The researchers emphasized that “it is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome, which takes decades to develop.” The researchers point out that the trials used to test the vaccine may have “overestimated” the efficacy of the vaccine.
Another interesting thing to note about HPV infections is when it comes to women in particular, approximately 70 percent of those who get an infection will clear it all by themselves within the first year, you don’t even have to detect it. Keep in mind that only a handful of HPV infections can actually lead to cancer. Within two years, approximately 90 percent of these infections will clear all by themselves. By three years, 10 percent of that original group will still have an HPV infection, and 5 percent of this 10 percent will have progressed into what are known as a precancerous lesion. There are three types of precancerous lesions, CIN1, which requires no treatment, C1N2 and the most severe, CIN3.
So now you have that small group (the remaining 5 percent)…who have precancerous lesions and now let’s look at that moving into invasive carcinoma. What we know then is that amongst women with CIN3 lesions, it takes five years for about twenty percent of them to become invasive carcinomas. That’s a pretty slow process. It takes about thirty years for forty percent of them to become invasive cervical carcinomas. – Dr. Diane Harper, one of a select few specialists in OB/GYN (in the world) who helped design and carry out the Phase II and Phase III safety and effectiveness studies to get Gardasil approved.
In a study published in Autoimmunity Reviews, the authors note that “The decision to vaccinate with the HPV vaccine is a personal decision, not one that must be made for public health. HPV is not a lethal disease, in 95 percent of the infections; and the other 5 percent are detectable and treatable in the precancerous state.”
This is why cervical cancer is usually diagnosed among the elderly, because it takes a long time to develop. This means that one has a very long time to treat pre-cancerous lesions that have the potential to develop into full blown cancer.
Not only is the efficacy of the vaccine called into question by many researchers, the supposed protection it provides, if any, only lasts a few years. Ask yourself, how likely is it for your 11 year old daughter/son to develop an HPV infection that will lead to cancer in a few decades, before she’s/he’s even done high school? The main cause of HPV infections is sexual intercourse.
Harper told CBS a few years ago that “the benefits (of the vaccine) to public health is noting, there is no reduction in cervical cancer.” She also emphasized that parents “must know that deaths occured” and that not all deaths have been reported. This information is accurate, we know this in the United States, for example, because of the National Childhood Vaccine Injury Compensation Program. It stems from the National Childhood Vaccine Injury act, which protects pharmaceutical companies from liability and uses tax-dollars to pay for vaccine injuries. Multiple countries have a program like this in place, and the United States has now paid more than $4 billion to families of vaccine injured children. The main takeaway is that the FDA Vaccine Adverse Events Reporting System (VAERS) is estimated to capture only 1 percent of vaccine injuries.
A study published in 2013 in Current Pharmaceutical Design carried out a review of HPV vaccine pre- and post-licensure trials to assess the evidence of their effectiveness and safety. They found that,
HPV vaccine clinical trials design, and data interpretation of both efficacy and safety outcomes, were largely inadequate. Additionally, we note evidence of selective reporting of results from clinical trials (i.e., exclusion of vaccine efficacy figures related to study subgroups in which efficacy might be lower or even negative from peer-reviewed publications). Given this, the widespread optimism regarding HPV vaccines long-term benefits appears to rest on a number of unproven assumptions (or such which are at odds with factual evidence) and significant misinterpretation of available data.
For example, the claim that HPV vaccination will result in approximately 70% reduction of cervical cancers is made despite the fact that the clinical trials data have not demonstrated to date that the vaccines have actually prevented a single case of cervical cancer (let alone cervical cancer death), nor that the current overly optimistic surrogate marker-based extrapolations are justified. Likewise, the notion that HPV vaccines have an impressive safety profile is only supported by highly flawed design of safety trials and is contrary to accumulating evidence from vaccine safety surveillance databases and case reports which continue to link HPV vaccination to serious adverse outcomes (including death and permanent disabilities).
We thus conclude that further reduction of cervical cancers might be best achieved by optimizing cervical screening (which carries no such risks) and targeting other factors of the disease rather than by the reliance on vaccines with questionable efficacy and safety profiles.
Not long ago researchers from Mexico’s National Institute of Cardiology looked at 28 studies published through January 2017—16 randomized trials and 12 post-marketing case series—pertaining to the three HPV vaccines currently on the market globally. In their July 2017 peer-reviewed report, the authors, Manuel Martínez-Lavin and Luis Amezcua-Guerra, uncovered evidence of numerous adverse events, including life-threatening injuries, permanent disabilities, hospitalizations and deaths, reported after vaccination with GlaxoSmithKline’s bivalent Cervarix vaccine and Merck’s quadrivalent or nine-valent HPV vaccines.
Mary Holland, a former a professor on the faculties of Columbia Law School and the New York University School of Law for the past eighteen years who taught courses on human rights, recently retired as the Director of the NYU Graduate Lawyering Program. She co-authored a book titled “The HPV Vaccine On Trial: Seeking Justice For A Generation Betrayed.”
The HPV Vaccine on Trial is a shocking tale, chronicling the global efforts to sell and compel this alleged miracle. The book opens with the vaccine’s invention, winds through its regulatory labyrinths, details the crushing denial and dismissal of reported harms and deaths, and uncovers the enormous profits pharma and inventors have reaped. Authors Holland, Mack Rosenberg, and Iorio drill down into the clinical trial data, government approvals, advertising, and personal accounts of egregious injuries that have followed in countries as far-flung as Japan, Australia, Colombia, India, Ireland, the U.K. and Denmark. The authors have written an unprecedented exposé about this vaunted vaccine.
Written in plain language, the book is for everyone concerned – parents, patients, doctors, nurses, scientists, healthcare organizations, government officials, and schools. Ultimately, this book is not just about the HPV vaccine, but about how industry, government, and medical authorities may be putting the world’s children in harm’s way.
A study published in the journal Pediatrics found that many paediatricians don’t strongly recommend the HPV vaccine. Since then it’s now known that vaccine hesitancy is rising among many doctors, scientists, academics and people of all backgrounds and professions. The question to ask is, why?
At a World Health Organization (WHO) conference on vaccine safety, Dr. Heidi Larson a Professor of Anthropology and the Risk and Decision Scientist Director at the Vaccine Confidence Project Emphasized this point, having stated,
The other thing that’s a trend, and an issue, is not just confidence in providers but confidence of health care providers. We have a very wobbly health professional frontline that is starting to question vaccines and the safety of vaccines. That’s a huge problem, because to this day any study I’ve seen…still, the most trusted person on any study I’ve seen globally is the health care provider.
A study published in the journal EbioMedicine as far back as 2013 outlines this point, stating in the introduction,
Over the past two decades several vaccine controversies have emerged in various countries, including France, inducing worries about severe adverse effects and eroding confidence in health authorities, experts and science. These two dimensions are at the core of vaccine hesitancy (VH) observed in the general population. VH is defined as delay in acceptance of vaccination, or refusal, or even acceptance with doubts about its safety and benefits, with all these behaviours and attitudes varying according to context , vaccine and personal profile, despite the availability of vaccine services VH presents a challenge to physicians who must address their patients’ concerns about vaccines and ensure satisfactory vaccination coverage.
A Typical Response From Merck For A Supposed Vaccine Injury? A 14-year-old boy named Christopher Bunch passed away more than a year ago, and the mother and father claimed that it was as a result of the HPV vaccine. His mother started a petition over a year ago claiming that her son “died as a direct result of the HPV vaccine.”
The father of the boy, Elijah Eugene Mendoza-Bunch, wrote this via his Facebook page, in January of 2020.
So back on December 11th 2019 I sent an email to CEO Ken Frazier of Merck song to speak with him about the HPV VACCINE and how it killed my son and how it is destroying lives. Well here we are January 25th (the day I got it in the mail) and this is the response from Merck….
As you can see, the letter states that,
“The safety and efficacy of our HPV vaccines have been established in a clinical development program that started more than 20 years ago and involved more than 49,000 individuals. Safety has continued to be evaluated after approval in multiple studies in several million people, in long-term follow up studies and through our extensive ongoing pharmacovigilance monitoring program in place throughout the world. Multiple independent scientific organizations and major regulatory and public health authorities, including the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and the U.S. Food and Drug Administration (FDA) have repeatedly evaluated the safety of HPV vaccines. The results of these evaluations continue to be reassuring
Is Aluminum a Concern? The HPV vaccine does use an aluminum adjuvant, something that’s come under fire over the past few years. You can read and learn more about that here.
The Takeaway: This isn’t even the tip of the iceberg, there are many papers published in various journals over the past decade pointing out the same thing. There are also many published studies and papers that claim the vaccine is completely safe and very effective. This is why it can be a confusing topic to look into and why we believe that informed consent in place of an HPV vaccine mandate for children should be in place.
What do you think? One thing is for certain, people should be free to engage in conversations about controversial topics. This is one thing the mainstream fails to do, and always seems to deem the type of information presented in this article as a result of “anti vax conspiracy theorists.” Instead of using ridicule, it would be great if the concerns being raised about vaccine safety were actually spoken about openly and transparently, and most importantly, actually acknowledged and addressed.
Do we really want to live in a world where we can’t talk to each other? Why do we have such a hard time seeing from the perspective of another and trying to understand where they are coming from and why they feel the way they do? Do we really want to create a world where we are forced into certain actions by our government at the threat of losing certain rights and privileges?A world where we are so polarized? Should people not be free to do what they want with their body, especially if the evidence to suggest that they are harming others if they don’t is weak and unsubstantiated?
When it comes to vaccines specifically, a quote from a paper published in the International Journal for Crime, Justice and Social Democracy by professor Paddy Rawlinson, from Western Sydney University, provides some good insight into what I am referring to.
Critical criminology repeatedly has drawn attention to the state-corporate nexus as a site of corruption and other forms of criminality, a scenario exacerbated by the intensification of neoliberalism in areas such as health. The state-pharmaceutical relationship, which increasingly influences health policy, is no exception. That is especially so when pharmaceutical products such as vaccines, a burgeoning sector of the industry, are mandated in direct violation of the principle of informed consent. Such policies have provoked suspicion and dissent as critics question the integrity of the state-pharma alliance and its impact on vaccine safety. However, rather than encouraging open debate, draconian modes of governance have been implemented to repress and silence any form of criticism, thereby protecting the activities of the state and pharmaceutical industry from independent scrutiny. The article examines this relationship in the context of recent legislation in Australia to intensify its mandatory regime around vaccines. It argues that attempts to undermine freedom of speech, and to systematically excoriate those who criticise or dissent from mandatory vaccine programs, function as a corrupting process and, by extension, serve to provoke the notion that corruption does indeed exist within the state-pharma alliance.